---
layout: post
title: "药明生物连续5天获南向资金净买入"
date: 2022-02-17 08:36:18 +0800
categories: zhengquanshibaowang
tags: 证券时报网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02269" data-code="02269|116|5" data-code2="02269|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02269&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02269_0" data-code="K 02269|116|5" data-code2="K 02269|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>证券时报网讯，2月16日上榜的港股通成交活跃股中，药明生物通过港股通渠道成交金额为9.27亿港元，净买入金额为5.52亿港元，不仅如此，该股已连续5日出现成交净买入，累计净买入金额22.04亿港元。<br /></p><p class="em_media">（文章来源：证券时报网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202172279267611>

[返回证券时报网新闻](//finews.withounder.com/category/zhengquanshibaowang.html)｜[返回首页](//finews.withounder.com/)